S-adenosylhomocysteine (AdoHcy)-dependent methyltransferase inhibitor DZNep overcomes breast cancer tamoxifen resistance via induction of NSD2 degradation and suppression of NSD2-driven redox homeostasis-Reference-Cited by-同舟云学术

S-adenosylhomocysteine (AdoHcy)-dependent methyltransferase inhibitor DZNep overcomes breast cancer tamoxifen resistance via induction of NSD2 degradation and suppression of NSD2-driven redox homeostasis

Published:2020-02 Issue: Volume:317 Page:108965
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Wang Qianqian,Zheng Jianwei,Zou June X.,Xu Jianzhen,Han Fanghai,Xiang Songtao,Liu Peiqing,Chen Hong-Wu,Wang Junjian

Funder

National Natural Science Foundation of China

Guangdong Natural Science Funds for Distinguished Young Scholar

science and Technology Planning Project of Guangdong Province

National Institutes of Health

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference32 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA A Cancer J. Clin.,2018

2. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer;Harvey;J. Clin. Oncol.,1999

3. Aromatase inhibitors for breast cancer: lessons from the laboratory;Johnston;Nat. Rev. Canc.,2003

4. Mechanisms of tamoxifen resistance;Ring;Endocr. Relat. Canc.,2004

5. WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck;Saloura;Mol. Canc. Res.,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucose-6-phosphate dehydrogenase and transketolase: Key factors in breast cancer progression and therapy;Biomedicine & Pharmacotherapy;2024-07

2. EZH2: The roles in targeted therapy and mechanisms of resistance in breast cancer;Biomedicine & Pharmacotherapy;2024-06

3. Dznep, a histone modification inhibitor, inhibits HIF1α binding to TIMP2 gene and suppresses TIMP2 expression under hypoxia;Physiological Reports;2023-09

4. Drug Discovery Targeting Nuclear Receptor Binding SET Domain Protein 2 (NSD2);Journal of Medicinal Chemistry;2023-08-14

5. Xanthatin induce DDP‐resistance lung cancer cells apoptosis through regulation of GLUT1 mediated ROS accumulation;Drug Development Research;2023-06